Figure 3.
Comparison of the mean fluorescent intensity (MFI) in HER2 amplified cell line ARK 2 after treatment with dacomitinib at a concentration of 0.140μM in different time course for phosphorylated HER2 (a) and S6 (b). Comparison of the MFI in cell line ARK-2 after 8 hours exposure to different dose of dacomitinib for phosphorylated HER2 (c) and S6 (d).